Table 3 Comparison of inflammation-related biomarkers at diagnosis between AAV patients with each poor outcome and those without

Variables

Surviving patients (N = 71)

Deceased patients (N = 5)

P-value

 GA (%)

13.8 (2.7)

14.3 (4.9)

0.933

 HbA1c (%)

5.6 (0.7)

5.3 (1.6)

0.339

 GA/HbA1c

2.4 (0.5)

2.5 (0.3)

0.530

Variables

Patients without relapse (N = 53)

Patients with relapse (N = 23)

P-value

 GA (%)

14.1 (2.8)

13.3 (2.5)

0.246

 HbA1c (%)

5.6 (0.8)

5.5 (0.5)

0.139

 GA/HbA1c

2.4 (0.5)

2.4 (0.5)

0.968

Variables

Patients without ESRD (N = 68)

Patients with ESRD (N = 8)

P-value

 GA (%)

13.6 (2.4)

15.8 (2.1)

0.019

 HbA1c (%)

5.6 (0.7)

5.6 (1.5)

0.766

 GA/HbA1c

2.4 (0.5)

2.7 (0.8)

0.074